BloodStor® 55-5
Optimized biopreservation reagent for hematopoietic cells and tissues
-
BloodStor® 55-5 -
BloodStor® 55-5 -
Label for BloodStor® 55-5
More Views
Overview
BloodStor® is a series of generic cGMP freeze media products used to cryopreserve stem cells and other cells isolated from umbilical cord blood, peripheral blood, bone marrow, and other biologics. All BloodStor® products are formulated using USP grade components and water for injection (WFI) quality water. BloodStor® 55-5 is pre-formulated with 55% (w/v) DMSO USP, 5% (w/v) Dextran-40 USP, and WFI quality water.
Advantages:
• Ready-to-use
• Animal component-free
• Sterile, USP vial
• cGMP manufactured with USP grade / highest-quality components
• Sterility, endotoxin, and cell-based release testing
• Animal component-free
• Sterile, USP vial
• cGMP manufactured with USP grade / highest-quality components
• Sterility, endotoxin, and cell-based release testing
Contains:
• 55% (w/v) dimethyl sulfoxide (DMSO)
• 5% (w/v) Dextran-40
• Other ingredients
• 5% (w/v) Dextran-40
• Other ingredients
Cell Type:
Hematopoietic Stem and Progenitor Cells
Species:
Human; Mouse; Rat; Non-Human Primate; Other
Brand:
BloodStor
Area of Interest:
Cord Blood Banking; Stem Cell Biology
Formulation:
Animal Component-Free; Serum-Free
Related Products
-
Defined, serum-free cryopreservation medium for human ES and iPS cells -
Biopreservation reagent for cells and tissues -
Animal component-free, defined cryopreservation medium with 5% DMSO -
Animal component-free, defined hypothermic (2 - 8°C) preservation medium for a range of cell and tissue types
Scientific Resources
Product Documentation
Document Type
Product Name
Catalog #
Lot #
Language
Educational Materials
(2)
Product Applications
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Research Area
Workflow Stages for
Workflow Stages
THIS PRODUCT IS MANUFACTURED UNDER A cGMP QUALITY MANAGEMENT SYSTEM COMPLIANT TO 21 CFR 820.